• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

19
3
2
2
2

COUNTRY

2
1
1
1
1

CATEGORIES

  • 12
  • 8
  • 5
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1

PRICE

0
0
3
32

PUBLISHED

1
1
5
32

PRODUCT TYPE

32

Search "Type 2 Diabetes - Pipeline Assessment and Market Forecasts to 2017" returned 32 results.

Diabetes Care Devices Market to 2017 - Artificial Pancreas to Be the Key Technology Driver for the Market

Diabetes Care Devices Market to 2017 - Artificial Pancreas to Be the Key Technology Driver for the Market Summary GBI Research’s report, “Diabetes Care Devices Market to 2017 - Artificial Pancreas...

April 2011
FROM

Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care Segment

GBI Research’s report, “Diabetes Care Devices in Emerging Countries (China, India, Brazil) to 2017 - Greater Awareness is Increasing Demand for Self-Monitoring of Blood Glucose (SMBG) in the Home Care...

March 2012
FROM

Diabetes - KOL Insight and Consensus Outlook Modules

The medium term: battle lines are drawn The fundamental drivers of the global diabetes market are strong and continue to fuel growth. Rising levels of obesity and disease prevalence in both established...

September 2013
FROM

Diabetes, Metabolic Syndrome and Cardiovascular Disease 2014

There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease--sometimes...

November 2014
FROM
Aleglitazar (Type 2 Diabetes) - Analysis and Forecasts to 2020 Aleglitazar (Type 2 Diabetes) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Aleglitazar (Type 2 Diabetes) - Analysis and Forecasts to 2020

Aleglitazar (Type 2 Diabetes) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Aleglitazar (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Aleglitazar sales...

January 2012
FROM
ASP1941 (Type 2 Diabetes) - Analysis and Forecasts to 2020 ASP1941 (Type 2 Diabetes) - Analysis and Forecasts to 2020 - Product Thumbnail Image

ASP1941 (Type 2 Diabetes) - Analysis and Forecasts to 2020

ASP1941 (Type 2 Diabetes) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “ASP1941 (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides ASP1941 sales estimates...

January 2012
FROM
Amaryl (Type 2 Diabetes) - Analysis and Forecasts to 2020 Amaryl (Type 2 Diabetes) - Analysis and Forecasts to 2020 - Product Thumbnail Image

Amaryl (Type 2 Diabetes) - Analysis and Forecasts to 2020

Amaryl (Type 2 Diabetes) – Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Amaryl (Type 2 Diabetes) – Analysis and Forecasts to 2020” provides Amaryl sales estimates for...

January 2012
FROM

Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development

“Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development” provides insights into the unmet needs...

July 2011
FROM

Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Insulin Delivery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData’s new report, “Insulin Delivery Devices - Global Pipeline Analysis, Competitive...

January 2012
FROM

Cardiovascular Devices Market to 2017 - Minimally Invasive Techniques and Cardiac Prosthetic Devices to Drive Future Growth

Cardiovascular Devices Market to 2017 - Minimally Invasive Techniques and Cardiac Prosthetic Devices to Drive Future Growth Summary GBI Research’s report, “Cardiovascular Devices Market to 2017 -...

February 2012
FROM

Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData’s new report, “Insulin Pumps - Global Pipeline Analysis, Competitive Landscape and Market...

December 2011
FROM

PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 Summary Type 1 diabetes (T1D) is an autoimmune disease that permanently destroys beta cells of the pancreatic islet,...

March 2015
FROM

OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017

OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 Summary GlobalData has released its new report, “OpportunityAnalyzer: Nonalcoholic Steatohepatitis...

September 2013
FROM

OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update

OpportunityAnalyzer: Nonalcoholic Steatohepatitis (NASH) - Opportunity Analysis and Forecasts to 2017 - Event-Driven Update Summary GlobalData has released its new Opportunity Analyzer report, “OpportunityAnalyzer:...

March 2014
FROM

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022

PharmaPoint: Microvascular Complications of Diabetes - Global Drug Forecast and Market Analysis to 2022 Summary The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy,...

December 2013
FROM

Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData’s new report, “Continuous Glucose Monitoring (CGM) Systems...

January 2012
FROM

Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData’s new report, “Renal Dialysis Equipment - Global Pipeline Analysis, Competitive...

June 2011
FROM

Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Cataract Surgery Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData’s new report, “Cataract Surgery Devices - Global Pipeline Analysis, Competitive...

January 2012
FROM

Renal Dialysis Services - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017

Renal Dialysis Services - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017 Summary GlobalData’s new report, “Renal Dialysis Services - Global Opportunity Assessment,...

November 2011
FROM

PharmaPoint: Neuropathic Pain - Japan Drug Forecast and Market Analysis to 2022

PharmaPoint: Neuropathic Pain - Japan Drug Forecast and Market Analysis to 2022 Summary Neuropathic pain (NP) is defined as a disorder of the sensorimotor system and is distinctly different from nociceptive...

April 2014
FROM
Loading Indicator

Our Clients

Amneal Pharmaceuticals LLC. Amgen Inc. LEO Laboratories Ltd. Pfizer, Inc. Roche Diagnostics Ltd. Merck & Co., Inc. Sanofi S.A.